What is Gulf War Illness and why is recognition important?
Beatrice Golomb, professor of medicine at the University of California San Diego, seeks to inform.
Faculty Bio:
Dr. Golomb is a Professor of Medicine at UC San Diego with over 15 years of experience treating veteran patients, including veterans with Gulf War Illness (GWI). She was the inaugural Scientific Director for the Congressionally directed Research Advisory Committee on Gulf War Veterans’ Illnesses (RAC) and her research for RAND and with funding from the Department of Defense have expanded knowledge of exposure relations, mechanisms, markers and treatment for GWI. Dr. Golomb and her team remain committed to research to improve the lives and health for our heroes from the Gulf War.
Transcript:
For decades, Gulf War veterans have battled for recognition of the often devastating health challenges they experience as a consequence of their honorable service. Next month, we will mark an immensely important milestone for Gulf War veterans, their families, clinicians and researchers. Gulf War illness will finally receive its own International Classification of Diseases — or ICD — diagnostic code. This is more than just administrative coding. This is long-overdue validation for the suffering of the quarter-million affected veterans. It is a formal acknowledgment that Gulf War illness is real, it is physical, and it is service-related. Gulf War illness affects about one-third of the nearly 700,000 U.S. troops who served in the 1990-1991 Gulf War. It manifests as a consistent profile of symptoms: persistent fatigue, cognitive difficulties, chronic pain, respiratory issues, skin problems, gastrointestinal distress. Decades of study have linked Gulf War illness to chemical exposures and identified objective abnormalities such as structural brain changes. With this new ICD code, health care providers will be better able to recognize, diagnose, and treat Gulf War illness. Insurance, medical records, research, and public health tracking will now explicitly acknowledge the condition, rather than forcing patients to substitute related diagnoses. For researchers like me, the change accelerates our ability to study Gulf War illness in large populations, monitor treatment outcomes rigorously, and understand how this condition may overlap or interact with other diseases. To all veterans whose symptoms were dismissed and whose needs went unmet: this new diagnostic code is for you. It’s a recognition of your service. It’s a commitment to your care. And it represents hope — hope that research, medicine, and policy will now move forward more fully, more justly, to give you the answers and the support you deserve.
Read More:
[PNAS] - Acetylcholinesterase inhibitors and Gulf War illnesses
[ScienceDirect] - Adverse effect propensity: A new feature of Gulf War illness predicted by environmental exposures
[National Library of Medicine] - Mitochondrial impairment but not peripheral inflammation predicts greater Gulf War illness severity
